Publication | Closed Access

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer

OncologyPaclitaxel-carboplatin AloneMedicineMetronomic TherapyBronchial NeoplasmPlacebo-controlled StudyCancer TreatmentPharmacologyLung Cancer